OBJECTIVE: The aim of this project is to specify features of family life that are associated with disease management in African Americans with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 159 African-American patients with type 2 diabetes were assessed on three domains of family life (structure/organization, world view, and emotion management) and three key dimensions of disease management (morale, management behaviors, and glucose regulation). Analyses assessed the associations of family factors with disease management. RESULTS: Multivariate tests for the main effects of three family variables were significantly related to the block of disease management variables for morale (F=3.82; df=12,363; P <0.0001) and behavior (2.12; 9,329; P <0.03). Structural togetherness in families was positively related to diabetes quality of life (DQOL)-Satisfaction (P <0.01). High family coherence, a world view that life is meaningful and manageable, was positively associated with general health (P <0.05) and DQOL-Impact (P <0.05) and negatively associated with depressive symptoms (P <0.001). Emotion management, marked by unresolved family conflict about diabetes, was related to more depressive symptoms (P <0.001), lower DQOL-Satisfaction (P <0.01), and lower DQOL-Impact (P <0.001). No family measures were related to HbA1c levels. CONCLUSIONS: The family domain of emotion management demonstrates the strongest associations with diabetes management in African-American patients, followed by family beliefs. Patient morale is the aspect of disease management that seems most related to family context.
OBJECTIVE: The aim of this project is to specify features of family life that are associated with disease management in African Americans with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 159 African-American patients with type 2 diabetes were assessed on three domains of family life (structure/organization, world view, and emotion management) and three key dimensions of disease management (morale, management behaviors, and glucose regulation). Analyses assessed the associations of family factors with disease management. RESULTS: Multivariate tests for the main effects of three family variables were significantly related to the block of disease management variables for morale (F=3.82; df=12,363; P <0.0001) and behavior (2.12; 9,329; P <0.03). Structural togetherness in families was positively related to diabetes quality of life (DQOL)-Satisfaction (P <0.01). High family coherence, a world view that life is meaningful and manageable, was positively associated with general health (P <0.05) and DQOL-Impact (P <0.05) and negatively associated with depressive symptoms (P <0.001). Emotion management, marked by unresolved family conflict about diabetes, was related to more depressive symptoms (P <0.001), lower DQOL-Satisfaction (P <0.01), and lower DQOL-Impact (P <0.001). No family measures were related to HbA1c levels. CONCLUSIONS: The family domain of emotion management demonstrates the strongest associations with diabetes management in African-American patients, followed by family beliefs. Patient morale is the aspect of disease management that seems most related to family context.
Authors: Carmen D Samuel-Hodge; Crystal W Cene; Leonor Corsino; Chelsea Thomas; Laura P Svetkey Journal: J Gen Intern Med Date: 2012-10-05 Impact factor: 5.128
Authors: Yuhua Bao; George S Alexopoulos; Lawrence P Casalino; Thomas R Ten Have; Julie M Donohue; Edward P Post; Bruce R Schackman; Martha L Bruce Journal: Arch Gen Psychiatry Date: 2011-06
Authors: Shelagh A Mulvaney; Eniola Mudasiru; David G Schlundt; Cara L Baughman; Mary Fleming; Ann VanderWoude; William E Russell; Tom A Elasy; Russell Rothman Journal: Diabetes Educ Date: 2008 Jul-Aug Impact factor: 2.140
Authors: Patrick J Raue; Herbert C Schulberg; Roberto Lewis-Fernandez; Carla Boutin-Foster; Amy S Hoffman; Martha L Bruce Journal: Int J Geriatr Psychiatry Date: 2010-11 Impact factor: 3.485
Authors: Helena H Laroche; Matthew M Davis; Jane Forman; Gloria Palmisano; Heather Schacht Reisinger; Cheryl Tannas; Michael Spencer; Michele Heisler Journal: Am J Prev Med Date: 2009-12 Impact factor: 5.043